MidFirst Bank’s Jupiter Neurosciences JUNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32 Hold
13
– – ﹤0.01% 865
2026
Q2
$214 Hold
13
– – ﹤0.01% 901
2026
Q1
$376 Hold
13
– – ﹤0.01% 846
2025
Q4
$1.02K Buy
+13
New +$1.3K ﹤0.01% 709

Other funds holding JUNS

MidFirst Bank's JUNS Position: Q3 2026 in Review

MidFirst Bank held its Jupiter Neurosciences (JUNS) position steady in Q3 2026 at 13 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #865.

MidFirst Bank first reported a position in JUNS in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.02K in Q4 2025. 8 funds tracked by Wall St. Rank hold JUNS as of Q3 2026.

  • MidFirst Bank held 13 shares of Jupiter Neurosciences worth $32 as of Q3 2026.
  • MidFirst Bank left its Jupiter Neurosciences share count unchanged in Q3 2026.
  • Jupiter Neurosciences made up ﹤0.01% of MidFirst Bank's portfolio in Q3 2026, its #865 holding.
  • MidFirst Bank first reported a position in Jupiter Neurosciences in Q4 2025 and has held it in 4 quarters since.
  • MidFirst Bank's Jupiter Neurosciences position peaked at $1.02K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q3 2026.

Based on MidFirst Bank's 13F filing for Q3 2026, filed 16 Nov 2026.